What is the first-line treatment for Diabetic nephropathy?
Diabetic nephropathy (diabetic kidney disease) requires a structured, multi-component first-line approach. Lifestyle modification forms the foundation of care, and specific pharmacological therapy is indicated depending on the patient's clinical profile. Blood pressure control is a central, measurable goal throughout management.
First-line management combines reinforced lifestyle interventions with targeted pharmacological therapy where clinical features indicate it. The full protocol details the specific agents, criteria, and dose-titration targets — only the starting point is outlined here.
Systolic blood pressure control to a defined numeric threshold is the primary endpoint guiding therapy. An alternative target applies when the primary threshold is not tolerated.
References
DOI: 10.1016/j.nefro.2024.11.002
- Lifestyle interventions must be an important part of care for people with diabetes and CKD and should be reinforced, as low sodium intake, physical exercise and smoking cessation are cornerstones of treatment.
- We recommend blood pressure (BP) control with a target systolic blood pressure (SBP) of <130 mm Hg, when tolerated, in patients with diabetic kidney disease.
- Otherwise, a general target of SBP < 140 mm Hg is recommended.